ERIS LIFESCIENCES
Quarterly Results Analysis [Dec2023]
ERIS LIFESCIENCES Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹486 Cr | ₹505 Cr | ₹467 Cr | ₹403 Cr | ₹423 Cr | ₹461 Cr | ₹399 Cr | ₹306 Cr |
Expenses | ₹311 Cr | ₹324 Cr | ₹297 Cr | ₹284 Cr | ₹286 Cr | ₹309 Cr | ₹269 Cr | ₹209 Cr |
Operating Income | ₹176 Cr | ₹181 Cr | ₹170 Cr | ₹119 Cr | ₹137 Cr | ₹151 Cr | ₹129 Cr | ₹97 Cr |
Other Income | ₹4 Cr | ₹3 Cr | ₹1 Cr | ₹1 Cr | ₹2 Cr | ₹5 Cr | ₹3 Cr | ₹8 Cr |
Interest | ₹18 Cr | ₹16 Cr | ₹17 Cr | ₹9 Cr | ₹3 Cr | ₹7 Cr | ₹7 Cr | ₹1 Cr |
Depreciation | ₹46 Cr | ₹42 Cr | ₹41 Cr | ₹35 Cr | ₹30 Cr | ₹29 Cr | ₹23 Cr | ₹18 Cr |
Profit Before Tax | ₹116 Cr | ₹126 Cr | ₹112 Cr | ₹76 Cr | ₹107 Cr | ₹121 Cr | ₹101 Cr | ₹85 Cr |
Profit After Tax | ₹101 Cr | ₹122 Cr | ₹94 Cr | ₹61 Cr | ₹100 Cr | ₹119 Cr | ₹93 Cr | ₹80 Cr |
EPS | ₹7.55 | ₹9.07 | ₹6.98 | ₹4.81 | ₹7.49 | ₹8.85 | ₹6.96 | ₹5.91 |
Industry Peers & Returns | 1W | 1M | 1Y |
ERIS LIFESCIENCES | -1% | 1.4% | 34.4% |
SUN PHARMACEUTICAL INDUSTRIES | -1.5% | -5.8% | 55.3% |
CIPLA | -5.9% | -8.4% | 45.7% |
DR REDDYS LABORATORIES | -6.1% | -4.1% | 19.8% |
ZYDUS LIFESCIENCES | -3.7% | -1.8% | 84.3% |
DIVIS LABORATORIES | -4.3% | -0.1% | 15.3% |
MANKIND PHARMA | -2% | -5.1% | NA |
TORRENT PHARMACEUTICALS | -4.2% | 0.1% | 51.3% |
LUPIN | -4.2% | -0.2% | 116.4% |
ERIS LIFESCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -3.76 % |
Y-o-Y | 14.89 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹486 Cr | -3.76 | |
Sep2023 | ₹505 Cr | 8.29 | |
Jun2023 | ₹467 Cr | 15.85 | |
Mar2023 | ₹403 Cr | -4.83 | |
Dec2022 | ₹423 Cr | -8.09 | |
Sep2022 | ₹461 Cr | 15.54 | |
Jun2022 | ₹399 Cr | 30.28 | |
Mar2022 | ₹306 Cr | - |
ERIS LIFESCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -3.11 % |
Y-o-Y | 27.92 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹176 Cr | -3.11 | |
Sep2023 | ₹181 Cr | 6.72 | |
Jun2023 | ₹170 Cr | 42.77 | |
Mar2023 | ₹119 Cr | -13.34 | |
Dec2022 | ₹137 Cr | -9.41 | |
Sep2022 | ₹151 Cr | 17.21 | |
Jun2022 | ₹129 Cr | 33.35 | |
Mar2022 | ₹97 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 0.67 % |
Y-o-Y | 11.32 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 36.09% | 0.67 | |
Sep2023 | 35.85% | -1.46 | |
Jun2023 | 36.38% | 23.24 | |
Mar2023 | 29.52% | -8.95 | |
Dec2022 | 32.42% | -1.43 | |
Sep2022 | 32.89% | 1.45 | |
Jun2022 | 32.42% | 2.37 | |
Mar2022 | 31.67% | - |
ERIS LIFESCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | -17.05 % |
Y-o-Y | 1.23 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹101 Cr | -17.05 | |
Sep2023 | ₹122 Cr | 30.61 | |
Jun2023 | ₹94 Cr | 52.33 | |
Mar2023 | ₹61 Cr | -38.66 | |
Dec2022 | ₹100 Cr | -16.04 | |
Sep2022 | ₹119 Cr | 28.26 | |
Jun2022 | ₹93 Cr | 16.38 | |
Mar2022 | ₹80 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | -13.84 % |
Y-o-Y | -11.91 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 20.86 % | -13.84 | |
Sep2023 | 24.21 % | 20.63 | |
Jun2023 | 20.07 % | 31.52 | |
Mar2023 | 15.26 % | -35.56 | |
Dec2022 | 23.68 % | -8.64 | |
Sep2022 | 25.92 % | 11.01 | |
Jun2022 | 23.35 % | -10.67 | |
Mar2022 | 26.14 % | - |
ERIS LIFESCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | -16.76 % |
Y-o-Y | 0.80 % |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹7.55 | -16.76 | |
Sep2023 | ₹9.07 | 29.94 | |
Jun2023 | ₹6.98 | 45.11 | |
Mar2023 | ₹4.81 | -35.78 | |
Dec2022 | ₹7.49 | -15.37 | |
Sep2022 | ₹8.85 | 27.16 | |
Jun2022 | ₹6.96 | 17.77 | |
Mar2022 | ₹5.91 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD